Perrigo Company plc Stock price

Equities

PRGO

IE00BGH1M568

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
32.19 USD +2.32% Intraday chart for Perrigo Company plc +2.84% +0.03%
Sales 2024 * 4.65B Sales 2025 * 4.88B Capitalization 4.26B
Net income 2024 * -35M Net income 2025 * 102M EV / Sales 2024 * 1.6 x
Net Debt 2024 * 3.16B Net Debt 2025 * 2.91B EV / Sales 2025 * 1.47 x
P/E ratio 2024 *
-83.9 x
P/E ratio 2025 *
71.5 x
Employees 9,140
Yield 2024 *
3.5%
Yield 2025 *
3.73%
Free-Float 99.12%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.14%
1 week+0.51%
Current month+19.80%
1 month+15.24%
3 months-1.84%
6 months-0.10%
Current year-2.24%
More quotes
1 week
30.71
Extreme 30.71
32.01
1 month
25.77
Extreme 25.77
32.01
Current year
25.77
Extreme 25.77
34.60
1 year
25.77
Extreme 25.77
40.28
3 years
25.77
Extreme 25.77
50.90
5 years
25.77
Extreme 25.77
63.86
10 years
25.77
Extreme 25.77
215.73
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 23-06-29
Director of Finance/CFO 49 22-05-15
Chief Tech/Sci/R&D Officer - 14-12-31
Members of the board TitleAgeSince
Chairman 55 20-12-14
Director/Board Member 68 17-02-05
Director/Board Member 67 17-02-05
More insiders
Date Price Change Volume
24-03-28 32.19 +2.32% 1 583 391
24-03-27 31.46 +2.14% 1,263,732
24-03-26 30.8 -0.68% 1,256,077
24-03-25 31.01 -0.99% 1,480,333
24-03-22 31.32 -0.82% 1,648,571

Delayed Quote Nyse, March 27, 2024 at 04:00 pm EDT

More quotes
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
31.46 USD
Average target price
38.75 USD
Spread / Average Target
+23.17%
Consensus
  1. Stock
  2. Equities
  3. Stock Perrigo Company plc - Nyse